Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy

Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy

Objective: Recent studies revealed the effect of valproate (VPA) on brain structural changes in idiopathic generalized epilepsy (IGE). We aimed to investigate the volume of the entire hippocampus and subfields in patients with IGE, and explored their associations with VPA use. Methods: A total of 21...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiang Huang, Yingying Zhang, Qiuxing Lin, Kailing Huang, Yuming Li, Peiwen Liu, Danyang Cao, Wenhao Li, Wei Li, Xiuli Li, Qiyong Gong, Dong Zhou, Dongmei An
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	NeuroImage: Clinical
Subjects:	Valproate Hippocampus Idiopathic Generalized Epilepsy HippUnfold
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158225000142
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01)

Cognitive Effects of Topiramate and Valproate
by: J Gordon Millichap
Published: (2003-06-01)

Valproate Metabolites and Hyperammonemia
by: J Gordon Millichap
Published: (1992-07-01)

Valproate, Carnitine, and Lipid Metabolism
by: J Gordon Millichap
Published: (1990-06-01)

Carbamazepine Vs Valproate and Cognitive Function
by: J Gordon Millichap
Published: (1996-10-01)

Valproate Induced Obesity and Polycystic Ovaries
by: J Gordon Millichap
Published: (1996-06-01)

Valproate and Carbamazepine Comparative Trial
by: J Gordon Millichap
Published: (1995-03-01)

Valproate-Induced Pubertal Arrest
by: J Gordon Millichap
Published: (1992-08-01)

Cognitive Deficits in Children Exposed to Valproate in Utero
by: J Gordon Millichap
Published: (2005-07-01)

Valproate, Learning Disorders, and Epileptiform EEG
by: J Gordon Millichap
Published: (2000-12-01)

Unveiling Thrombocytopenia Trends In Pediatric Epilepsy: The Valproate Connection
by: Kiran Nayab, et al.
Published: (2025-01-01)

Case report and literature review of refractory hypoalbuminemic ascites caused by so-dium valproate
by: Hui-Min YANG, et al.
Published: (2021-10-01)

Hereditary Susceptibility to Fetal Valproate Syndrome
by: J Gordon Millichap
Published: (2002-09-01)

The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model
by: Ahmed Sudan Abbas, et al.
Published: (2024-09-01)

EXPERIENCE GENERIC VALPROATE IN ADULTS WITH FOCAL EPILEPSY (RESULTS THE OBSERVATIONS IN MOSCOW HEALTH FACILITY OUTPATIENT NETWORK)
by: I. Yu. Artemova, et al.
Published: (2016-05-01)

Valproate-Induced Hepatic Failure with Cox Deficit
by: J Gordon Millichap
Published: (1994-03-01)

USE OF INJECTABLE VALPROATE FORMULATIONS IN STATUS EPILEPTICUS IN ADULTS AND CHILDREN
by: A. A. Kholin
Published: (2015-04-01)

Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety—a case report
by: Wei Chen, et al.
Published: (2025-07-01)

A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01)

Anxiolytic and sedative effects of sodium valproate with different experimental paradigms in male and female rats
by: María de losÁngeles Cintado, et al.
Published: (2024-12-01)

EPILEPSY AT ADULTS: GENDER COMORBIDE DISORDERS, APPLICATION OF VALPROATES
by: P. N. Vlasov
Published: (2016-06-01)

Cerebroprotective prevention of memory disorders using sodium valproate
by: A. V. Ivanov
Published: (2013-04-01)

Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate
by: Mami Uegami, et al.
Published: (2025-01-01)

EXPERIENCE OF PROLONGED VALPROATE USE IN ADULT PATIENTS WITH FOCAL FORMS OF EPILEPSY (RESULTS OF OBSERVATION HELD IN OUT-PATIENT CLINICS OF MOSCOW)
by: S. G. Burd, et al.
Published: (2016-09-01)

Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
by: N. A. Shnayder, et al.
Published: (2025-06-01)

Prevention of disorders of behavioral reactions in rats using nootropics with sodium valproate
by: Ivanov A.V.
Published: (2013-06-01)

Latvian Healthcare Professionals’ Self-Reported Knowledge, Attitudes, and Behaviors Related to Pregnancy Prevention Program Materials for Valproate-Containing Medicines
by: Milana Špoģe, et al.
Published: (2024-12-01)

Targeting oxidative stress and metal imbalance in cerebral ischemia: the neuroprotective role of sodium valproate
by: Mustafa Ulaş, et al.
Published: (2025-07-01)

Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma
by: Junchen Liu, et al.
Published: (2025-01-01)

Revisiting Childhood Gratification Disorder: Clinical Diagnosis and the Role of Sodium Valproate in Management
by: Suparna Kumar, et al.
Published: (2025-02-01)

Behavioral features of Wistar rats in models of autism spectrum disorders induced by prenatal or postnatal administration of sodium valproate
by: E. V. Savinkova, et al.
Published: (2024-08-01)

Mitochondrial protection and anti-inflammatory effect of curcumin in inhibiting reproductive toxicity induced by sodium valproate in male mice
by: Moein Shaneh, et al.
Published: (2025-08-01)

Study Assessing Use of Mood Stabilizers (Sodium Valproate and Oxcarbazepine) as an Augmentation Strategy in Patients of Treatment-resistant Depression
by: Priya Chugh, et al.
Published: (2025-04-01)

Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism
by: Wei Zhou, et al.
Published: (2025-07-01)

Safety and tolerability of antiepileptic therapy: emphasis on the use of valproates (literature review)
by: O. A. Pylaeva, et al.
Published: (2020-01-01)

A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
by: Emi Hata, et al.
Published: (2025-01-01)

Region-specific hippocampal atrophy is correlated with poor glycemic control in type 2 diabetes: a cross-sectional study
by: Cuiping Bao, et al.
Published: (2023-12-01)

Phytochemical, In Silico, In Vitro, and In Vivo Research on Piptadeniastrum africanum (Fabaceae) Unveiling Anti‐Stereotypic, Anxiolytic, and Analgesic Effects in a Sodium Valproate‐Induced Autistic Disorders Model
by: Ambani Omgba Jeanne Julie, et al.
Published: (2025-03-01)

Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest–posttest design study
by: Rehab H. Werida, et al.
Published: (2025-03-01)

Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
by: Lyudmila Tikhonova, et al.
Published: (2025-04-01)